[1]
2025. Deep learning predicts HER2 status in invasive breast cancer from multimodal ultrasound and MRI. Biomolecules and Biomedicine. 25, 10 (May 2025), 2243–2251. DOI:https://doi.org/10.17305/bb.2025.12475.